Population-based Assessment of Survival After Cytoreductive Nephrectomy Versus No Surgery in Patients With Metastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Population-based Assessment of Survival After Cytoreductive Nephrectomy Versus No Surgery in Patients With Metastatic Renal Cell Carcinoma

Published:2009-02 Issue:2 Volume:73 Page:342-346
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Zini Laurent,Capitanio Umberto,Perrotte Paul,Jeldres Claudio,Shariat Shahrokh F.,Arjane Philippe,Widmer Hugues,Montorsi Francesco,Patard Jean-Jacques,Karakiewicz Pierre I.

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. Radical nephrectomy plus interferon alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial;Mickisch;Lancet,2001

2. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer;Flanigan;N Engl J Med,2001

3. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995;Albertsen;J Urol,2000

4. Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole;Cottin;Ann Oncol,1999

5. Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators;Taylor;J Clin Oncol,1994

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and bioequivalence of sunitinib and Sutent® in Chinese healthy subjects: an open-label, randomized, crossover study;Frontiers in Pharmacology;2023-11-10

2. Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC;Nature Reviews Urology;2023-07-03

3. Racial and ethnic disparities in surgery for kidney cancer: a SEER analysis, 2007–2014;Ethnicity & Health;2023-05-10

4. Laparoscopic cytoreductive nephrectomy is associated with significantly improved survival compared with open cytoreductive nephrectomy or targeted therapy alone;Molecular and Clinical Oncology;2020-09-21

5. Surgical Consideration in Renal Tumors;Kidney Cancer;2019-11-28